Solid Biosciences Inc.

Solid Biosciences Inc.verified

SLDB

Price:

$5.92

Market Cap:

$461.22M

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new ...[Read more]

Industry

Biotechnology

IPO Date

2018-01-26

Stock Exchange

NASDAQ

Ticker

SLDB

The Enterprise Value as of December 2025 (TTM) for Solid Biosciences Inc. (SLDB) is 421.79M

According to Solid Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 421.79M. This represents a change of 60.47% compared to the average of 262.85M of the last 4 quarters.

Solid Biosciences Inc. (SLDB) Historical Enterprise Value (quarterly & annually)

How has SLDB Enterprise Value performed in the past?

The mean historical Enterprise Value of Solid Biosciences Inc. over the last ten years is 284.17M. The current 421.79M Enterprise Value has changed 14.74% with respect to the historical average. Over the past ten years (40 quarters), SLDB's Enterprise Value was at its highest in in the September 2018 quarter at 1.47B. The Enterprise Value was at its lowest in in the December 2022 quarter at -83684020.00.

Quarterly (TTM)
Annual

Average

284.17M

Median

177.18M

Minimum

-81042440.00

Maximum

806.30M

Solid Biosciences Inc. (SLDB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Solid Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 121.21%

Maximum Annual Enterprise Value = 806.30M

Minimum Annual Increase = -216.15%

Minimum Annual Enterprise Value = -81042440.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024107.21M44.22%
202374.34M-191.73%
2022-81042440.00-216.15%
202169.77M-71.41%
2020244.04M121.21%
2019110.32M-86.32%
2018806.30M19.09%
2017677.08M58.45%
2016427.30M5.15%

Solid Biosciences Inc. (SLDB) Average Enterprise Value

How has SLDB Enterprise Value performed in the past?

The current Enterprise Value of Solid Biosciences Inc. (SLDB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

33.50M

5-year avg

82.86M

10-year avg

284.17M

Solid Biosciences Inc. (SLDB) Enterprise Value vs. Peers

How is SLDB’s Enterprise Value compared to its peers?

Solid Biosciences Inc.’s Enterprise Value is greater than Autolus Therapeutics plc (358.55M), greater than Quantum-Si incorporated (276.42M), greater than Rocket Pharmaceuticals, Inc. (319.22M), less than LB Pharmaceuticals Inc Common Stock (467.73M), greater than Aura Biosciences, Inc. (320.33M), greater than Benitec Biopharma Inc. (252.27M), less than Annexon, Inc. (432.32M), greater than Neumora Therapeutics, Inc. Common Stock (251.41M), less than Design Therapeutics, Inc. (540.75M), less than RAPT Therapeutics, Inc. (534.71M),

Build a custom stock screener for Solid Biosciences Inc. (SLDB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solid Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Solid Biosciences Inc. (SLDB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Solid Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Solid Biosciences Inc.'s Enterprise Value?

What is the highest Enterprise Value for Solid Biosciences Inc. (SLDB)?

What is the 3-year average Enterprise Value for Solid Biosciences Inc. (SLDB)?

What is the 5-year average Enterprise Value for Solid Biosciences Inc. (SLDB)?

How does the current Enterprise Value for Solid Biosciences Inc. (SLDB) compare to its historical average?